Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2017

Dec 8, 2017

30403_dirs_2017-12-08_91df3b84-c282-46d4-af32-835f5e19fa3a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2017-12-01

Reporting Person: Mowery Andrew J (SVP-Chief Product Supply)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3047.0000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $57.2500 2019-09-15 Common Stock (6270.0000) Direct
Stock Option (Right to Buy) $66.4800 2020-09-14 Common Stock (6990.0000) Direct
Stock Option (Right to Buy) $68.1500 2021-09-13 Common Stock (6100.0000) Direct
Stock Option (Right to Buy) $72.1100 2022-09-11 Common Stock (8120.0000) Direct
Stock Option (Right to Buy) $84.4500 2023-09-17 Common Stock (6110.0000) Direct
Stock Option (Right to Buy) $89.8200 2024-09-17 Common Stock (16930.0000) Direct
Stock Option (Right to Buy) $111.6000 2025-09-15 Common Stock (12360.0000) Direct
Stock Option (Right to Buy) $123.0900 2026-09-13 Common Stock (11830.0000) Direct
Stock Option (Right to Buy) $135.5700 2027-09-12 Common Stock (10650.0000) Direct

Footnotes

F1: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.